纳米载体
材料科学
阿霉素
生物相容性
纳米技术
细胞毒性
内吞作用
药物输送
生物物理学
癌细胞
纳米颗粒
谷胱甘肽
化学
体外
细胞
生物化学
癌症
化疗
医学
冶金
酶
外科
内科学
生物
作者
Shen‐Zhen Ren,Dan Zhu,Xiaohua Zhu,Bin Wang,Yu‐Shun Yang,Wen-Xue Sun,Xiaoming Wang,Peng‐Cheng Lv,Zhong‐Chang Wang,Hai‐Liang Zhu
标识
DOI:10.1021/acsami.9b04236
摘要
Responsive nanocarriers with biocompatibility and precise drug releasing capability have emerged as a prospective candidate for anticancer treatment. However, the challenges imposed by the complicated preparation process and limited loading capacities have seriously impeded the development of novel multifunctional drug delivery systems. Here, we developed a novel and dual-responsive nanocarrier based on a nanoscale ZIF-8 core and an organosilica shell containing disulfide bridges in its frameworks through a facile and efficient strategy. The prepared ZIF-8@DOX@organosilica nanoparticles (ZDOS NPs) exhibited a well-defined structure and excellent doxorubicin (DOX) loading capability (41.2%) with pH and redox dual-sensitive release properties. The degradation of the organosilica shell was observed after 12 h incubation with a 10 mM reducing agent. Confocal imaging and flow cytometry analysis further proved that the nanocarriers can efficiently enter cells and complete intracellular DOX release under the low pH and high glutathione concentrations, which resulted in an enhanced cytotoxicity of DOX for cancer cells. Meanwhile, subcellular localization experiments revealed that the ZDOS NPs entered cells mainly by endocytosis and then escaped from lysosomes into the cytosol. Moreover, in vivo assays also demonstrated that the ZDOS NPs exhibited negligible systemic toxicity and significantly enhanced anticancer efficiencies compared with free DOX. In summary, our prepared pH and redox dual-responsive nanocarriers provide a potential platform for controlled release and cancer treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI